Prevention and treatment of ischemia-reperfusion and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/675 (2006.01) A61K 31/00 (2006.01) A61K 31/52 (2006.01)

Patent

CA 2186915

Methods of preventing or treating ischemia-reperfusion injury in an organ by administration of a composition containing a selective A1 adenosine receptor antagonist and/or a P2x purinoceptor antagonist are provided. Method of preventing or treating endotoxin-related lung injury by administration of a composition containing a selective A1 adenosine receptor antagonist and/or a P2x purinoceptor antagonist are also provided.

Prévention et traitement des lésions résultant de l'ischémie consécutive à une reperfusion dans un organe par administration d'une composition renfermant un antagoniste de récepteur d'adénosine A¿1? sélectif et/ou un antagoniste de purinorécepteur P¿2x?. L'invention porte également sur des méthodes de prévention ou de traitement des lésions pulmonaires liées à l'endotoxine par administration d'une composition renfermant un antagoniste de récepteur d'adénosine A¿1? sélectif et/ou un antagoniste de purinorécepteur P¿2x?.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prevention and treatment of ischemia-reperfusion and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention and treatment of ischemia-reperfusion and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of ischemia-reperfusion and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1806668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.